Clinical Trial Detail

NCT ID NCT03579316
Title Adavosertib With or Without Olaparib in Treating Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors M.D. Anderson Cancer Center
Indications

peritoneum cancer

fallopian tube cancer

ovary epithelial cancer

Therapies

Olaparib

MK-1775 + Olaparib

Age Groups: adult senior

No variant requirements are available.